Tori Rodriquez, MA, LPC, AHC

A look into increased cardiovascular risk in patients who are transgender and suggestions for how to improve their health care.

In this Q&A, Drs Serota and Thakarar discuss the dual subspecialty of infectious disease and addiction medicine and its role in combating the ongoing opioid epidemic.

Saraschandra Vallabhajosyula, MD, and Ibrahim Sultan, MD, discuss the relationship between the weekend effect and poor prognosis following cardiac emergencies.

Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.

Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.

A look into the growing number of cases of stress cardiomyopathy, also known as Takotsubo syndrome, that have been observed during the COVID-19 pandemic.

About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.

A significant number of cases of post-COVID-19 myocarditis have been reported.

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

Since pulse oximetry technology was developed in nondiverse populations, racial bias may influence the accuracy of pulse oximeter readings.